AppointmentsHat Trick Of Senior Appointments At Fast-Growing Love Hemp...

Hat Trick Of Senior Appointments At Fast-Growing Love Hemp Group


LOVE Hemp Group has unveiled a trio of senior management appointments as it looks to grow both the brand and its investment portfolio.

The UK-based CBD and hemp products supplier has appointed chief operating, communications and growth officers, all of which become effective immediately.

James Martin has joined the team full-time as COO to implement the company’s global and growth strategies. He has more than 1 5 years’ experience driving large-scale strategic operational excellence and business transformation programmes across a number of industries, including fast-moving consumer goods, technology, healthcare and pharmaceuticals.

Previous employers include Shell, Vodafone, GlaxoSmithKline, and PwC.

Anna Legge will become chief communications officer with the task of developing and managing all external stakeholder engagement, including investor relations, corporate media announcements and environmental, social and governance reporting.

Anne Legge

Previously director of communications of London and Toronto listed SolGold plc and with experience of working at a large international communications agency advising firms such as Muberry, Centrica, Bunnings and UP Global Sourcing, she has a strong background in capital markets.

The final appointment is Martin Healy as chief growth officer. He brings 15 years’ experience from the sports, media and entertainment industries, and will drive Love Hemp’s international growth and commercial relationships, allowing chief commercial officer, Adam Pritchard, to focus on expanding the company’s established UK market presence.

Martin Healy

Love Hemp Group chief executive, Tony Calamita, said: “I am excited to welcome James, Anna and Martin to the growing senior management team at Love Hemp Group. “They each bring significant experience in their respective fields of expertise, with the ability to execute the dynamic and impactful strategies required to grow the Love Hemp brand and our investment profile.”

Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

Germany Seeing Sense, High Tide Strikes Deal With Major German Player, European Expansion For Bedrocan, Danish Buy-Out, Greek First, £2m UK Hemp Boost

THE German Government’s refreshingly honest approach to drugs and addiction is being demonstrated with a focus on the harms...

European Cannabis Stocks Review: Akanda Announces ‘First Significant Revenue Above Initial Projections’, Jazz Pharma Reimbursement Recommendation & Kanabo Climbs

Akanda  Akanda has enjoyed a sharp recovery in its share price this week, seeing its value return to levels not...

15% Of European Consumers Have Tried CBD, But Industry Held Back By ‘High Turnover Rate’ Of Users

THE European CBD market is set to see a ‘massive influx’ of previous and new consumers to the market...

Malta’s Pioneering Legal Cannabis Club Framework Announced, But Concerns Raised Licence Fees Could Push Many To Black Market

ON Friday (January 27) the Maltese Authority for the Responsible Use of Cannabis (ARUC) announced new guidelines set to...

Cannovum AG Establishes Cultivation Alliance For Germany

PRESS RELEASE CANNOVUM AG is currently founding the premier cultivation alliance for recreational cannabis in Germany. The aim of the...

Jazz Pharmaceuticals Receives NICE Recommendation For The Reimbursement Of Epidyolex (Cannabidiol) For The Treatment Of Seizures Associated With Tuberous Sclerosis Complex In England

PRESS RELEASE JAZZ Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Epidyolex® (cannabidiol,100 mg/mL oral solution), developed by GW Pharmaceuticals ("GW"; now...

Must read

You might also likeRELATED
Recommended to you